LYDRAGEN Minimally Invasive Makes a Starry Debut at CSIH 2025, with Innovative Products Pioneering a New Era of Precision Treatment in Bariatric and Metabolic Surgery!

The inaugural China Symposium on Comprehensive Management of Bariatric and Metabolic Surgery (CSIH2025) was recently held with great success. As a pioneer of innovation in the field of minimally invasive surgery in China, LYDRAGEN Minimally Invasive showcased its core products—the electric endoscopic cutting stapler and the 75-mm ultra-long staple cartridge—drawing widespread attention from the industry by leveraging cutting-edge technology to advance the precision and efficiency of bariatric and metabolic surgical procedures.

CSIH2025 brings together leading experts and scholars from China and abroad to jointly explore the cutting-edge trends and clinical practices in the field of bariatric metabolic surgery. At this year’s exhibition, LYDRAGEN Minimally Invasive is showcasing its disposable electric laparoscopic cutting and anastomosis device and staple cartridge assembly, which, thanks to its core advantages of “electric drive plus intelligent feedback,” enables precise control over both cutting and anastomosis. A particular highlight is the newly introduced 75-mm ultra-long staple cartridge, which has become one of the standout features of the event. Made from high-strength titanium alloy and manufactured using precision molding techniques, this cartridge not only ensures reliable anastomotic outcomes but also allows for single-pass transection of longer tissue segments, thereby reducing the number of instrument exchanges during surgery, shortening operative time, and providing a superior solution for laparoscopic procedures such as gastric bypass and sleeve gastrectomy.

LYDRAGEN Minimally Invasive has consistently been driven by clinical needs, leveraging a robust R&D team and collaborative platforms integrating industry, academia, and research to continuously break through technological barriers in minimally invasive surgical instrumentation. Looking ahead, LYDRAGEN Minimally Invasive will remain focused on the precision and intelligent advancement of surgical procedures, introducing more groundbreaking products and contributing to the development of obesity and metabolic surgery in China.